Anis Assad, Francesco Barletta, Reha-Baris Incesu, Lukas Scheipner, Simone Morra, Andrea Baudo, Cristina Cano Garcia, Zhe Tian, Sascha Ahyai, Nicola Longo, Felix K H Chun, Shahrokh F Shariat, Derya Tilki, Alberto Briganti, Fred Saad, Pierre I Karakiewicz
PURPOSE: The role of lymphadenectomy and the optimal lymph node count (LNC) cut-off in nonmetastatic adrenocortical carcinoma (nmACC) are unclear. METHODS: Within the Surveillance, Epidemiology, and End Results (SEER) database, surgically treated nmACC patients with T2-4 stages were identified between 2004 and 2020. We tested for cancer-specific mortality (CSM) differences according to pathological N-stage (pN0 vs. pN1) and two previously recommended LNC cut-offs (≥4 vs...
April 22, 2024: Urologic Oncology